Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

BACKGROUND: Epidermal growth factor receptor (EGFR) mutations in non–small-cell lung cancer predict sensitivity to EGFR tyrosine kinase inhibitors (TKIs). EGFR mutation types are associated with efficacy of EGFR TKIs. We investigated the clinical outcomes of afatinib, erlotinib, and gefitinib accord...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cancer
Hauptverfasser: Park, Sojung, Lee, Sung Yong, Kim, Dojin, Sim, Yun Su, Ryu, Jeong-Seon, Choi, Juwhan, Lee, Su Hwan, Ryu, Yon Ju, Lee, Jin Hwa, Chang, Jung Hyun
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7802134/
https://ncbi.nlm.nih.gov/pubmed/33430803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07765-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge